Spero Therapeutics Completes Patient Enrollment in Pivotal Phase 3 Clinical Trial (ADAPT-PO) of …,

The ADAPT-PO Phase 3 clinical trial of tebipenem HBr for the treatment of complicated urinary tract infection and acute pyelonephritis has completed …, The ADAPT-PO Phase 3 clinical trial of tebipenem HBr for the treatment of complicated urinary tract infection and acute pyelonephritis has completed …, Read More

Scroll to Top